Healthcare provider profile · identity verified

William A. Carrasco, MD

Internal Medicine · SACRAMENTO, CA · NPI 1740368281

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	543	189
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	482	85
Lisinopril	Lisinopril	392	132
Amlodipine Besylate	Amlodipine Besylate	310	97
Levothyroxine Sodium	Levothyroxine Sodium	294	90
Losartan Potassium	Losartan Potassium	269	88
Pantoprazole Sodium	Pantoprazole Sodium	232	66
Fluticasone Propionate	Fluticasone Propionate	195	67
Terazosin Hcl	Terazosin Hcl	192	48
Albuterol Sulfate Hfa	Albuterol Sulfate	190	72
Trazodone Hcl	Trazodone Hcl	175	51
Hydrochlorothiazide	Hydrochlorothiazide	152	53
Tamsulosin Hcl	Tamsulosin Hcl	148	49
Ozempic	Semaglutide	141	27
Gabapentin	Gabapentin	135	47
Alendronate Sodium	Alendronate Sodium	128	38
Simvastatin	Simvastatin	127	44
Metoprolol Tartrate	Metoprolol Tartrate	123	40
Metoprolol Succinate	Metoprolol Succinate	117	42
Furosemide	Furosemide	115	53
Metformin Hcl	Metformin Hcl	110	36
Nabumetone	Nabumetone	104	43
Glipizide	Glipizide	103	36
Ibuprofen	Ibuprofen	96	30
Alvesco	Ciclesonide	95	29
Omeprazole	Omeprazole	93	33
Meloxicam	Meloxicam	88	31
Atenolol	Atenolol	84	30
Allopurinol	Allopurinol	76	24
Spiriva Respimat	Tiotropium Bromide	72	21
Tizanidine Hcl	Tizanidine Hcl	72	suppressed
Famotidine	Famotidine	71	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	13
Metformin Hcl Er	Metformin Hcl	70	30
Zolpidem Tartrate	Zolpidem Tartrate	69	suppressed
Citalopram Hbr	Citalopram Hydrobromide	68	26
Ondansetron Hcl	Ondansetron Hcl	65	21
Triamcinolone Acetonide	Triamcinolone Acetonide	65	28
Rosuvastatin Calcium	Rosuvastatin Calcium	64	22
Duloxetine Hcl	Duloxetine Hcl	62	19
Jardiance	Empagliflozin	61	23
Potassium Chloride	Potassium Chloride	61	18
Prednisone	Prednisone	58	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	19
Wixela Inhub	Fluticasone Propion/Salmeterol	49	15
Carvedilol	Carvedilol	46	16
Fluoxetine Hcl	Fluoxetine Hcl	46	17
Eliquis	Apixaban	45	18
Methadone Hcl	Methadone Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	11
Doxycycline Monohydrate	Doxycycline Monohydrate	35	28
Acetaminophen-Codeine	Acetaminophen With Codeine	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	13
Acyclovir	Acyclovir	33	11
Colchicine	Colchicine	33	13
Dulera	Mometasone/Formoterol	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	15
Mirtazapine	Mirtazapine	32	15
Amoxicillin	Amoxicillin	31	16
Morphine Sulfate Er	Morphine Sulfate	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	13
Clobetasol Propionate	Clobetasol Propionate	29	17
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Nystatin	Nystatin	29	15
Naproxen	Naproxen	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	21
Lovastatin	Lovastatin	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Trospium Chloride	Trospium Chloride	25	11
Memantine Hcl	Memantine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Fluocinonide	Fluocinonide	23	15
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	23	15
Pradaxa	Dabigatran Etexilate Mesylate	22	suppressed
Latanoprost	Latanoprost	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Finasteride	Finasteride	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Humulin N	Insulin Nph Human Isophane	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	18	18
Cefadroxil	Cefadroxil	18	16
Cefpodoxime Proxetil	Cefpodoxime Proxetil	18	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lorazepam	Lorazepam	17	11
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Clonidine Hcl	Clonidine Hcl	16	suppressed
Estradiol	Estradiol	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Humulin R	Insulin Regular, Human	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Cephalexin	Cephalexin	14	13
Fenofibrate	Fenofibrate	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error